Literature DB >> 16907661

An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration.

Catherine Ulbricht1, Ethan Basch, Wendy Weissner, Dana Hackman.   

Abstract

Reported utilisation of prescription drug use concurrently with herbal or vitamin products have increased, placing an estimated 15 million patients at risk of potential drug-supplement interactions. This systematic review aims to consolidate relevant herb and supplement interactions data available for some of the more common classes of interactions experienced by clinicians. These classes include: hypoglycaemic/hyperglycaemics; hypotensive/hypertensives, diuretics, sedatives, cardiac glycosides, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, laxatives, immunomodulators, agents that may increase the risk of bleeding or clotting, agents that may be hepatotoxic, agents that may have hormonal properties, and agents with cytochrome P450 enzyme activity. The format is designed to promote use as a decision support tool for healthcare providers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907661     DOI: 10.1517/14740338.5.5.719

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  9 in total

Review 1.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?

Authors:  Dâmaris Silveira; Jose Maria Prieto-Garcia; Fabio Boylan; Omar Estrada; Yris Maria Fonseca-Bazzo; Claudia Masrouah Jamal; Pérola Oliveira Magalhães; Edson Oliveira Pereira; Michal Tomczyk; Michael Heinrich
Journal:  Front Pharmacol       Date:  2020-09-23       Impact factor: 5.810

2.  Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.

Authors:  Bill J Gurley; Ashley Swain; D Keith Williams; Gary Barone; Sunil K Battu
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

3.  Prevalence and predictors of children's dietary supplement use: the 2007 National Health Interview Survey.

Authors:  Johanna Dwyer; Richard L Nahin; Gail T Rogers; Patricia M Barnes; Paul M Jacques; Christopher T Sempos; Regan Bailey
Journal:  Am J Clin Nutr       Date:  2013-04-10       Impact factor: 7.045

4.  Prevalence of dietary supplement use in healthy pre-school Chinese children in Australia and China.

Authors:  Shu Chen; Colin W Binns; Bruce Maycock; Yi Liu; Yuexiao Zhang
Journal:  Nutrients       Date:  2014-02-21       Impact factor: 5.717

5.  Investigating Chemical Composition and Indications of Hydrosol Soft Drinks (Aromatic Waters) Used in Persian Folk Medicine for Women's Hormonal and Reproductive Health Conditions.

Authors:  Azadeh Hamedi; Mehdi Afifi; Hamed Etemadfard
Journal:  J Evid Based Complementary Altern Med       Date:  2017-07-13

6.  Butterbur (Petasites hybridus) Extract Ameliorates Hepatic Damage Induced by Ovalbumin in Mice.

Authors:  Rana M Alhusayan; Badr Abdullah Aldahmash; Doaa M El-Nagar; Ahmad Rady; Khalid Elfakki Ibrahim; Saad Alkahtani
Journal:  Oxid Med Cell Longev       Date:  2020-12-15       Impact factor: 6.543

Review 7.  A Practical Perspective on the Use of Botanicals During the COVID-19 Pandemic: From Proven to Potential Interactions.

Authors:  Alexander Bertuccioli; Marco Cardinali; Francesco Di Pierro; Simone Magi; Giordano Zonzini
Journal:  J Med Food       Date:  2021-11-17       Impact factor: 2.786

Review 8.  Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products.

Authors:  F Saverio Bersani; Marialuce Coviello; Claudio Imperatori; Marta Francesconi; Christina M Hough; Giuseppe Valeriani; Gianfranco De Stefano; Flaminia Bolzan Mariotti Posocco; Rita Santacroce; Amedeo Minichino; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-09-17       Impact factor: 3.411

Review 9.  Effectiveness of Stimulation of Acupoint KI 1 by Artemisia vulgaris (Moxa) for the Treatment of Essential Hypertension: A Systematic Review of Randomized Controlled Trials.

Authors:  Xiaochen Yang; Xingjiang Xiong; Guoyan Yang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-13       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.